Table 1.
Patient characteristics and perioperative outcomes, based on the surgical approach.
| Overall (n = 145) |
ORC (n = 102) |
RARC (n = 43) |
p | |
|---|---|---|---|---|
| Age, y | 77 (69/80) | 77 (69/80) | 76 (71/79) | 0.58 |
| Male gender, n (%) | 109 (75%) | 72 (71%) | 37 (86%) | 0.06 |
| BMI | 25.6 (24/27.68) | 25.6 (24/27.7) | 25.7 (23.7/27.9) | 0.97 |
| Diabetes, n (%) | 35 (24%) | 24 (23%) | 11 (26%) | 0.79 |
| Hypertension, n (%) | 95 (65%) | 68 (67%) | 27 (63%) | 0.65 |
| AMI, n (%) | 15 (10%) | 8 (8%) | 7 (16%) | 0.13 |
| ASA ≥ 3, n (%) | 98 (68%) | 70 (69%) | 28 (65%) | 0.68 |
| CCI | 4 (4/6) | 4 (4/6) | 4 (4/6) | 0.67 |
| NAC, n (%) | 24 (17%) | 17 (17%) | 7 (16%) | 0.95 |
| Hb at baseline, g/dL | 11.8 (10.2/13.1) | 11.5 (10/12.9) | 12.6 (10.7/13.4) | 0.05 |
| Hb at discharge, g/dL | 9.8 (9.1/10.8) | 9.5 (9/10.3) | 11.1 (10/12.1) | <0.001 |
| OT, min | 140 (101/172) | 120 (94/153) | 165 (150/210) | <0.001 |
| Time to flatus, d | 2 (2/3) | 3 (2/4) | 2 (1/2) | <0.001 |
| Time to bowel, d | 4 (3/5) | 5 (4/6) | 3 (3/4) | <0.001 |
| MBEs, n (%) | 117 (81%) | 91 (89%) | 26 (60%) | <0.001 |
| Postoperative compications, n (%) | ||||
| Clavien–Dindo grade < 3 | 123 (85%) | 96 (94%) | 27 (63%) | 0.04 |
| Clavien–Dindo grade ≥ 3 | 9 (6%) | 9 (8%) | 0 (0%) | <0.001 |
| LOS, d | 6 (4/8) | 7 (5/9) | 4 (3/5) | <0.001 |
| AJCC stage, n (%) | 0.07 | |||
| 0is-II | 38 (26%) | 22 (22%) | 16 (37%) | |
| IIIa | 80 (55%) | 60 (59%) | 20 (45%) | |
| IIIb | 19 (13%) | 16 (16%) | 3 (7%) | |
| IV | 8 (5%) | 4 (4%) | 4 (9%) | |
| Histopathology report, n (%) | 0.77 | |||
| TCC | 132 (91%) | 92 (90%) | 40 (93%) | |
| SCC | 6 (4%) | 5 (5%) | 6 (4%) | |
| Others | 7 (5%) | 5 (5%) | 7 (5%) | |
| 30d Complications, n (%) | 57 (39%) | 40 (39%) | 17 (39%) | 1.00 |
| Severe | 24 (16%) | 22 (22%) | 2 (5%) | 0.01 |
| Follow-up time, m | 10 (4/23) | 15 (7/32) | 6 (3/10) | <0.001 |
Data reported as median (IQR), ORC = open radical cystectomy, RARC = robotic assisted radical cystectomy, AMI = acute myocardial infarction, ASA = American Society of Anesthesiologists, CCI = Charlson Comorbidity Index, NAC = neoadjuvant chemotherapy, Hb = hemoglobin, OT = operation time, MBEs = major bleeding events, LOS = length of hospital stay, AJCC = American Joint Committee on Cancer, TCC = transitional cell carcinoma, SCC = squamous cell carcinoma, 30d Complications = complications at 30-day follow-up.